Market Announcements, page-19

Yeah baby. I bought some more at $1.30 a few weeks ago... and I bought plenty 3 years ago at 40 odd cents, sold some on the way up but hold enough. This stock if FY17 comes in as predicted could be well ahead of $3. Does the market still not understand the model or are they dubious of the accounting treatment of the biological assets? I see the discount rates used are 12-14% so that is being generous too.